• So you thought they were clean enough?...

      Kaur, Harpreet; Midland Regional Hospital, Tullamore (Midland Regional Hospital, Tullamore, 2012)
      The extensive use of cytotoxic drugs in the treatment of cancer patients represents a health risk for all staff involved in the preparation and handling of such drugs. This qualifies as an occupational health hazard and the two groups with the highest levels of exposure are pharmacists who dispense these drugs and nursing staff who administer them [1]. Equally other staff involved in their compounding, as well as logistical and training personnel are likely to be exposed.
    • Why does it take so long? ‘Lean processing’ in the aseptic compounding unit at the Midland Regional Hospital Tullamore

      Greene, C; Crimmins, É; Garvey, E; Midland Regional Hospital Tullamore (2011-06)
      Increasing numbers of oncology/haematology patients attending Midland Regional Hospital Tullamore (MRHT) has increased the workload of the Regional Oncology Haematology Pharmacy (ROHP) compounding unit. Staff restrictions require optimisation of current workflow practices. This audit (November 2010 and June 2011) focused on workflow in the aseptic compounding unit. In MRHT, ‘go-aheads’ are given by nurses and doctors. Drugs are compounded on an individual patient basis, except for batch production of bevacizumab and cetuximab. Focusing on the workflow process and comparing individual versus batch production in this audit may identify trends to improve efficiency.